rs370888932
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001267550.2(TTN):c.55973G>A(p.Arg18658Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000018 in 1,612,960 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001267550.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTN | NM_001267550.2 | c.55973G>A | p.Arg18658Gln | missense_variant | Exon 288 of 363 | ENST00000589042.5 | NP_001254479.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTN | ENST00000589042.5 | c.55973G>A | p.Arg18658Gln | missense_variant | Exon 288 of 363 | 5 | NM_001267550.2 | ENSP00000467141.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 151986Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000524 AC: 13AN: 248302 AF XY: 0.0000372 show subpopulations
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1460856Hom.: 0 Cov.: 32 AF XY: 0.00000826 AC XY: 6AN XY: 726742 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152104Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74358 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:2
The Arg16090Gln variant in TTN has not been reported in the literature nor previ ously identified by our laboratory. This variant has been identified in 1/8592 E uropean American chromosomes from a broad population by the NHLBI Exome Sequenci ng Project (http://evs.gs.washington.edu/EVS/;). This frequency is too low to ru le out a role in disease. Computational analyses (biochemical amino acid propert ies, conservation, AlignGVGD, Polyphen2, and SIFT) do not provide strong support for or against an impact to the protein. Additional information is needed to f ully assess the clinical significance of the Arg16090Gln variant. -
Missense variants in the TTN gene are considered 'unclassified' if they are not previously reported in the literature and do not have >1% frequency in the population to be considered a polymorphism. Research indicates that truncating mutations in the TTN gene are expected to account for approximately 25% of familial and 18% of sporadic idiopathic DCM; however, truncating variants in the TTN gene have been reported in approximately 3% of reported control alleles. There has been little investigation into non-truncating variants. (Herman D et al. Truncations of titin causing dilated cardiomyopathy. N Eng J Med 366:619-628, 2012) The variant is found in CARDIOMYOPATHY panel(s). -
not provided Uncertain:2
- -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at